What is Merck?
Founded in 1891 and headquartered in Rahway, NJ, Merck & Co., Inc. is a prominent global healthcare company. It is dedicated to delivering innovative solutions across a broad spectrum of health needs, including prescription medicines, advanced biologic therapies, essential vaccines, and comprehensive animal health products. Merck operates at the forefront of medical research and development, aiming to improve health outcomes worldwide.
How much funding has Merck raised?
Merck has raised a total of $20.9B across 7 funding rounds:
Debt
$2B
Debt
$2.5B
Debt
$6.5B
Debt
$3.1B
Debt
$1.1B
Debt
$5B
Private Equity
$700M
Debt (2010): $2B with participation from Undisclosed
Debt (2012): $2.5B led by Undisclosed
Debt (2013): $6.5B supported by Undisclosed
Debt (2014): $3.1B featuring Undisclosed
Debt (2016): $1.1B backed by Undisclosed
Debt (2019): $5B with participation from Undisclosed
Private Equity (2025): $700M led by Blackstone
Key Investors in Merck
Blackstone
Blackstone is a global investment firm specializing in private equity and alternative asset management, likely providing strategic capital for Merck's growth initiatives.
Undisclosed Investors
Undisclosed Investors
What's next for Merck?
The recent major strategic investment signals Merck's intent to further accelerate its research and development efforts, potentially expanding its therapeutic areas and global reach. This capital infusion is likely to support advancements in key areas such as oncology, vaccines, and infectious diseases, reinforcing Merck's commitment to tackling some of the world's most pressing health challenges. The company is poised for continued innovation and market leadership.
See full Merck company page
